Prostaglandin E[1] treatment in patent ductus arteriosus dependent congenital heart defects
-
G. Tálosi
, M. Katona , K. Rácz , E. Kertész , B. Onozó and S. Túri
Abstract
Prostaglandin E1 (PGE1) treatment can be life saving in patients suffering from ductus dependent congenital heart defect. We analyzed the indications and side-effects of PGE1 therapy over a five-year period. The purpose of the study was also to examine whether a change in serum electrolyte levels could be detected.
Forty-nine patients were treated with PGE1 during this period. PGE1 treatment was indicated by ductus dependent systemic circulation in 16 cases, ductus dependent pulmonary circulation in 17 cases, transposition of the great arteries in 13 cases and pulmonary hypertension (persistent fetal circulation) in three cases.
As early side-effects of the treatment, fever occurred in 27/49 cases while apnoea was observed in 15 patients. In a one-week-old neonate with coarctation of the aorta grade III intraventricular hemorrhage developed. A mild decrease of sodium, potassium and chloride levels and a slight shift of pH levels toward metabolic alkalosis could be detected after one day and one week of PGE1 treatment.
Because of these side-effects of PGE1 patients should be monitored in an intensive care unit. According to our observations electrolyte levels may exhibit a slight decrease; however, in the case of a short-term therapy extra salt supplementation is not necessary.
Copyright (c) 2004 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Publishers' note
- ‘Fetal programming’ and ‘functional teratogenesis’: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks
- The baby or the bathwater: which one should be discarded?
- Waterbirths compared with landbirths: an observational study of nine years
- Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance
- A 2 hour versus the 3 hour 100 g glucose tolerance test for diagnosing gestational diabetes mellitus
- Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome
- Changes in the size of maternal inferior vena cava during pregnancy
- Maternal plasma procalcitonin concentrations in patients with preterm labor and intact membranes - prediction of preterm delivery and admission-to-delivery interval
- Determinant factors in Ecuador related to pregnancy among adolescents aged 15 or less
- Different maternal serum hCG levels in pregnant women with female and male fetuses: does fetal hypophyseal – adrenal – gonadal axis play a role?
- Behavioral pattern continuity from prenatal to postnatal life a study by four-dimensional (4D) ultrasonography
- Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment
- Impact of phototherapy on vasoactive mediators: NO and VEGF in the newborn
- Reexpansion pulmonary edema following patent ductus arteriosus ligation in a preterm infant
- Prostaglandin E[1] treatment in patent ductus arteriosus dependent congenital heart defects
- Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis
- Atypical sonographic presentation of fetal unilateral inguinoscrotal hernia in a multiple gestation
- A case report of polysplenia syndrome associated with genital tract duplication anomaly
- Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria
Articles in the same Issue
- Publishers' note
- ‘Fetal programming’ and ‘functional teratogenesis’: on epigenetic mechanisms and prevention of perinatally acquired lasting health risks
- The baby or the bathwater: which one should be discarded?
- Waterbirths compared with landbirths: an observational study of nine years
- Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance
- A 2 hour versus the 3 hour 100 g glucose tolerance test for diagnosing gestational diabetes mellitus
- Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome
- Changes in the size of maternal inferior vena cava during pregnancy
- Maternal plasma procalcitonin concentrations in patients with preterm labor and intact membranes - prediction of preterm delivery and admission-to-delivery interval
- Determinant factors in Ecuador related to pregnancy among adolescents aged 15 or less
- Different maternal serum hCG levels in pregnant women with female and male fetuses: does fetal hypophyseal – adrenal – gonadal axis play a role?
- Behavioral pattern continuity from prenatal to postnatal life a study by four-dimensional (4D) ultrasonography
- Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment
- Impact of phototherapy on vasoactive mediators: NO and VEGF in the newborn
- Reexpansion pulmonary edema following patent ductus arteriosus ligation in a preterm infant
- Prostaglandin E[1] treatment in patent ductus arteriosus dependent congenital heart defects
- Maternal anaphylaxis and fetal brain damage after intrapartum chemoprophylaxis
- Atypical sonographic presentation of fetal unilateral inguinoscrotal hernia in a multiple gestation
- A case report of polysplenia syndrome associated with genital tract duplication anomaly
- Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria